A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
Authors:
- Christoph RoderburgChristoph Roderburg
- Fabian BenzFBFabian Benz
- Alexander KochAKAlexander Koch
- Sven H. LoosenSLSven H. Loosen
- Martina SpehlmannMSMartina Spehlmann
- Mark LueddeMLMark Luedde
- Alexander WreeAWAlexander Wree
- Mihael VucurMVMihael Vucur
- Christian TrautweinCTChristian Trautwein
- Frank TackeFrank Tacke
- Tom LueddeTLTom Luedde
Open Access
- 9 October 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1644
Abstract
Background and aims: Identification of patients with increased risk of mortality represents an important prerequisite for an adapted adequate and individualized treatment of critically ill patients. Circulating micro-RNA (miRNA) levels have been suggested as potential biomarkers at the intensive care unit (ICU), but none of the investigated miRNAs displayed a sufficient sensitivity or specificity to be routinely employed as a single marker in clinical practice. Methods and results: We recently described alterations in serum levels of 7 miRNAs (miR-122, miR-133a, miR-143, miR-150, miR-155, miR-192, and miR-223) in critically ill patients at a medical ICU. In this study, we re-analyzed these previously published data and performed a combined analysis of these markers to unravel their potential as a prognostic scoring system in the context of critical illness. Based on the Youden’s index method, cut-off values were systematically defined for dysregulated miRNAs, and a “miRNA survival score” was calculated. Patients with high scores displayed a dramatically impaired prognosis compared to patients with low values. Additionally, the predictive power of our score could be further increased when the patient’s age was additionally incorporated into this score. Conclusions: We describe the first miRNA-based biomarker score for prediction of medical patients’ outcome during and after ICU treatment. Adding the patients’ age into this score was associated with a further increase in its predictive power. Further studies are needed to validate the clinical utility of this score in risk-stratifying critically ill patients.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft ((DFG RO 4317/4-1))
- German Center for Cardiovascular Diseases (DZHK, B18-005Ext)
This publication has 32 references indexed in Scilit:
- miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 YearsMediators of Inflammation, 2019
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical IllnessDisease Markers, 2015
- Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseasesLiver International, 2014
- Clinical relevance of circulating cell-free microRNAs in cancerNature Reviews Clinical Oncology, 2014
- U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosisExperimental & Molecular Medicine, 2013
- A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsisCytokine, 2012
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic CancerTranslational Oncology, 2010
- Statistical Evaluation of a BiomarkerAnesthesiology, 2010
- MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with SepsisPLOS ONE, 2009